CAR T-Cell Immunotherapy Treating T-ALL: Challenges and Opportunities

Ren, AQ; Tong, XQ; Xu, N; Zhang, TC; Zhou, FL; Zhu, HC

Zhou, FL; Zhu, HC (通讯作者),Wuhan Univ Sci & Technol, Inst Biol & Med, Coll Life & Hlth Sci, Wuhan 430081, Peoples R China.;Zhou, FL (通讯作者),Zhongnan Hosp Wuhan Univ, Dept Hematol, Wuhan 430071, Peoples R China.

VACCINES, 2023; 11 (1):

Abstract

T-cell acute lymphoblastic leukemia (T-ALL), a form of T-cell malignancy, is a typically aggressive hematological malignancy with high rates of diseas......

Full Text Link